CABENUVA

Cabenuva

Cabenuva

(cabotegravir and rilpivirine)

Cabenuva is a 2-drug co-packaged product of cabotegravir, a HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).

Prescribing Information

Patient Information

Implementation Resources

ViiV resources on considerations to implement Cabenuva into clinical practice:

CABENUVA Implementation Guidance for Clinics

Considerations to Implement CABENUVA

The ABCs of CAB: Incorporating Long-Acting CABENUVA Into Clinical Practice

For information on select publicly available resources to help providers implement CABENUVA into clinical practice, visit the following:

AAHIVM Long-Acting Agents Resource Center (hivlaa.org)

HIVMA: Cabenuva Considerations for Health Care Providers long-acting-antiretroviral-treatment-considerations-for-health-care-providers.pdf (hivma.org)

NYSDOH AIDS Institute Guideline: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults - AIDS Institute Clinical Guidelines (hivguidelines.org)